A Multicenter, Open-label, Phase IIb Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia (LUMINA 2)
OPEN TO ACCRUAL
III
NCT05002777
ahsu2@BrownHealth.org
